Introducing pharmacogenomic decision support for medication risk assessment in people with polypharmacy

Polypharmacy has been shown to be a source of multiple adverse drug events. Recent studies demonstrated that pharmacogenomic testing may be instrumental in optimizing medication regimen. However, majority of current pharmacogenomic decision support tools provide assessment only of single drug-gene i...

Full description

Bibliographic Details

Published in:	2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) pp. 1803 - 1808
Main Authors:	Jiazhen Liu, Finkelstein, Joseph
Format:	Conference Proceeding
Language:	English
Published:	IEEE 01.11.2017
Subjects:	Additives adverse drug events Biochemistry decision support Drugs Genetics Inhibitors pharmacogenomics polypharmacy Substrates
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!